
    
      A Phase I, Single-center, 2-part, Randomized, 2-way Crossover Study to Assess the Local
      Tolerability and Safety (Multiple-dose) and to Assess the Pharmacokinetics, Safety, and
      Tolerability (Single-dose) of Ceftaroline in Healthy Subjects when Ceftaroline Fosamil is
      Diluted in Various Infusion Volume
    
  